2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168877 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiawei Ni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, p38 Mitogen-Activated Protein Kinases, Apoptosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Talent project of Shanghai Tongren Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Neonatal hypoxic-ischemic encephalopathy (HIE) is a critical condition characterized by significant brain damage due to insufficient blood flow and oxygen delivery at birth, leading to high rates of neonatal mortality and long-term neurological deficits worldwide. 2,3-Diphosphoglyceric acid (2,3-DPG), a small molecule metabolite prevalent in erythrocytes, plays an important role in regulating oxygen delivery, but its potential neuroprotective role in hypoxic-ischemic brain damage (HIBD) has yet to be fully elucidated. Our research reveals that the administration of 2,3-DPG effectively reduces neuron damage caused by hypoxia-ischemia (HI) both in vitro and in vivo. We observed a notable decrease in HI-induced neuronal cell apoptosis, attributed to the downregulation of Bax and cleaved-caspase 3, alongside an upregulation of Bcl-2 expression. Furthermore, 2,3-DPG significantly alleviates oxidative stress and mitochondrial damage induced by oxygen-glucose deprivation/reperfusion (OGD/R). The administration of 2,3-DPG in rats subjected to HIBD resulted in a marked reduction in brain edema and infarct volume, achieved through the suppression of neuronal apoptosis and neuroinflammation. Using RNA-seq analysis, we validated that 2,3-DPG offers protection against neuronal apoptosis under HI conditions by modulating the p38 MAPK pathway. These insights indicated that 2,3-DPG might act as a promising novel therapeutic candidate for HIE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
ORCID-Profile: Xirong Guo, Xiaohua Dong
Förderung
- The Talent project of Shanghai Tongren Hospital
- National Natural Science Foundation of China
Zitieren
APA
Ni, J., Zhao, J., Chen, H., Liu, W., Le, M., Guo, X., & Dong, X. (2024). 2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168877
Vancouver
Ni J, Zhao J, Chen H, Liu W, Le M, Guo X, et al. 2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168877
BibTeX
@article{Ni2024,
author = {Ni, Jiawei and Zhao, Jing and Chen, Haocong and Liu, Wenjuan and Le, Meini and Guo, Xirong and Dong, Xiaohua},
title = {2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168877}
}
EUVIMED